SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neurophet and RapidAI Partner to Expand Treatment Monitoring Access

The agreement expands Neurophet's reach into U.S. health systems and focuses on monitoring Alzheimer's and MS treatment.

Related stories